Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Autor: Fabio Vieira Teixeira, Rogerio Serafim Parra, Omar Feres, Paulo Gustavo Kotze
Jazyk: angličtina
Předmět:
Zdroj: Clinics, Vol 74
Druh dokumentu: article
ISSN: 1980-5322
DOI: 10.6061/clinics/2019/e1424
Databáze: Directory of Open Access Journals